[1] Song J, Yu J, Prayogo GW, et al. Understanding kidney injury molecule 1: a novel immune factor in kidney pathophysiology[J]. Am J Transl Res, 2019, 11: 1219-1229. [2] 马雪,张蓓茹,李德天.尿KIM-1蛋白诊断早期造影剂肾病的实验研究[J].南方医科大学学报, 2011,2: 357-360. [3] Lee HC, Sheu SH, Yen HW, et al. JNK/ATF2 pathway is involved in iondinated contrast media-induced apoptosis[J]. Am J Nephrol, 2010, 31: 125-133. [4] Tonomura Y, Tsuchiya N, Torii M, et al. Evaluation of the usefulness of urinary biomarkers for nephrotoxicity in rats[J]. Toxicology, 2010, 273:53-59. [5] Moresco RN, Bochi GV, Stein CS, et al. Urinary kidney injury molecule-1 in renal disease[J]. Clin Chim Acta, 2018, 487: 15-21. [6] Liao B, Nian W, Xi A, et al. Evaluation of a diagnostic test of serum neutrophil gelatinase-associated lipocalin(NGAL) and urine KIM-1 in contrast-induced nephro-pathy(CIN)[J]. Med Sci Monit, 2019, 25: 565-570. [7] Zhao X, Jiang C, Olufade R, et al. Kidney injury molecule-1 enhances endocytosis of albumin in renal proximal tubular cells[J]. J Cell Physiol, 2016, 231: 896-907. [8] Cai J, Jiao X, Luo W, et al. Kideny injury molecule-1 expression predicts structural damage and outcome in histological acute tubular injury[J]. Ren Fail, 2019, 41: 80-87. [9] Schulz CA, Engstrom G, Nilsson J, et al. Plasma kidney injury molecule-1(p-KIM-1) levels and deterioration of kidney function over 16 years[J]. Nephrol Dial Transplant, 2020,35:265-273. [10] Hisamichi M, Kamijo-Ikemori A, Sugaya T, et al. Increase in urinary markers during the acute phase reflects the degree of chronic tubulointerstitial injury after ischemia-reperfusion renal injury[J]. Biomarkers, 2017, 22: 5-13. [11] Humphreys BD, Xu F, Sabbisetti V, et al. Chronic epithelial kidney injury molecule-1 expression causes murine kidney fibrosis[J]. J Clin Invest, 2013, 123: 4023-4035. [12] Faucon AL, Bobrie G, Clement O. Nephrotoxicity of iodinated contrast media: From pathophysiology to prevention strategies[J]. Eur J Radiol, 2019, 116: 231-241. |